Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Wed Apr 02 13:44:04 GMT 2025
by
admin
on
Wed Apr 02 13:44:04 GMT 2025
|
| Protein Type | TRISPECIFIC ANTIBODY |
| Protein Sub Type | |
| Sequence Type | COMPLETE |
| Record UNII |
6R6GWJ8GDZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2839572-09-5
Created by
admin on Wed Apr 02 13:44:04 GMT 2025 , Edited by admin on Wed Apr 02 13:44:04 GMT 2025
|
PRIMARY | |||
|
C190202
Created by
admin on Wed Apr 02 13:44:04 GMT 2025 , Edited by admin on Wed Apr 02 13:44:04 GMT 2025
|
PRIMARY | |||
|
300000032865
Created by
admin on Wed Apr 02 13:44:04 GMT 2025 , Edited by admin on Wed Apr 02 13:44:04 GMT 2025
|
PRIMARY | |||
|
6R6GWJ8GDZ
Created by
admin on Wed Apr 02 13:44:04 GMT 2025 , Edited by admin on Wed Apr 02 13:44:04 GMT 2025
|
PRIMARY | |||
|
12958
Created by
admin on Wed Apr 02 13:44:04 GMT 2025 , Edited by admin on Wed Apr 02 13:44:04 GMT 2025
|
PRIMARY | |||
|
LM-96
Created by
admin on Wed Apr 02 13:44:04 GMT 2025 , Edited by admin on Wed Apr 02 13:44:04 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 4_136 | 4_196 |
| 4_23 | 4_89 |
| 3_136 | 3_196 |
| 3_23 | 3_89 |
| 2_366 | 2_424 |
| 2_260 | 2_320 |
| 2_219 | 4_216 |
| 1_219 | 3_216 |
| 2_143 | 2_199 |
| 2_22 | 2_96 |
| 1_602 | 1_676 |
| 1_553 | 1_624 |
| 1_476 | 1_541 |
| 1_366 | 1_424 |
| 1_353 | 2_348 |
| 1_260 | 1_320 |
| 1_228 | 2_228 |
| 1_225 | 2_225 |
| 1_143 | 1_199 |
| 1_22 | 1_96 |
| Glycosylation Type | MAMMALIAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_296 |
| N | 2_296 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
CC-92328 is designed to bind to BCMA expressed on MM cells to localize immune responses to the tumor microenvironment and to stabilize BCMA on the cell surface. When bound to MM cells, CC-92328 can concurrently bind to CD16a and NKG2D on effector cells (primarily NK cells), thus potentiating NK cell mediated killing of malignant cells and promoting the release of cytokines
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|